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http://dx.doi.org/10.1016/j.asjsur.20Summary Background: In this study, we have tried to demonstrate the effects of coating
style used in oxygenators on various hematologic and clinical parameters.
Materials and methods: Twenty-seven patients were included in the study, who had under-
gone operations because of elective coronary artery disease. Albumin-coated oxygenator
was used in Group I. In Group II, a synthetic polypeptide-coated oxygenator was used.
C1-inhib (complement), C3c, C4, interleukins (IL-1b, IL2, IL-6, IL-10), and tumor necrosis
factor alpha (TNF-a) levels were examined at four different time intervals. Hemoglobin, he-
matocrit, leukocyte and platelet counts, drainage, and transfused blood volumes were
analyzed.
Results: Albumin levels were significantly lower in Group I than those in Group II 5 minutes
after the removal of the cross-clamp. Twenty-four hours after the surgery, Group I patients
also had a significantly higher white blood cell count compared to Group II patients. TNF-a
levels in Group I were always expressed in considerably higher amounts than those in Group
II. IL-6 levels were significantly higher in Group I, but IL-10 levels were observed to be high-
er in Group II (p < 0.05).eclare that they have no financial or non-financial conflicts of interest related to the subject matter
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94 E. Simsek et al.Conclusion: Synthetic polypeptide-coated advanced technology, which employed oxygena-
tors, had an important attenuator effect on acute phase reactants and also on the inflam-
matory response.
Copyright ª 2013, Asian Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Systemic Inflammatory Response Syndrome (SIRS) can be
the result of coagulation system activation and inflamma-
tory reactions triggered by blood getting into contact with
nonbiological membranes during cardiopulmonary
bypass.1,2 SIRS is characterized by hypotension, coagulop-
athy, free oxygen radicals production, and platelet pro-
duction, which are significantly associated with morbidity
and mortality. It is thought that endothelial damage and
increased microvascular permeability may play a role in the
physiopathological mechanism of this syndrome.3
One of the most important immunological structures
affecting the inflammatory reactions that develop after
cardiopulmonary bypass (CPB) is the complement system.
The severity of the complement response alters depending
on the length of CPB4 and the circulation system used.5
During CPB, not only the existence of C3a, C5a, and
membrane attack complex (MAC), but also the consumption
of the complement components indicate the activation of
the complement system in the circulation.6 Considerable
complement activations occur within the first 3 days
following the CPB.7 During the bypass, the complement
system is activated by standard and alternative methods;
while the standard activation method leads to an increase
both in C3a and C4a, the alternative activation method
leads to an increase only in C3a.8 C3a begins to increase
with the start of CPB and reaches its peak at the end of the
bypass. C3a level depends on the length of the bypass and
reverts back to its standard level after 48 hours. C5a is
related to instant reperfusion. C5a triggers activated leu-
kocytes, therefore, increases superoxide production and
enables them to attach to the coronary artery
endothelium.9
There exist important peptides that function in inflam-
matory and repair roles in the regulation of an organism’s
immunity system. These peptides are generally called cy-
tokines. Cytokines play a role in both systemic and local
inflammation by regulating cell-to-cell communication.
These cytokines are functionally proinflammatory (IL-1,
IL8) and anti-inflammatory [IL-1RA (IL-1 receptor antago-
nist), IL-10]. IL-6 shows both characteristics. Proin-
flammatory cytokines such as IL-1a, IL-1b, and IL-6 may
turn out to be harmful mediators when plasma levels are
high in cases such as major trauma, sepsis, and shock.10 In
cardiac surgery, according to some observations, both pro
and anti-inflammatory cytokines expression increase in
order to provide an equilibrium between them.11
IL-1 has effects on the emergence of local neutrophil
infiltration, delayed type cell sensitivity, fibroplasias, and
angiogenesis. After IL-1 injection, local inflammatory
response begins. This reaction starts 1 hour after theinjection, reaching the peak value in 3-4 hours time. This
stimulates IL-6 expression. IL-1 injection induces tumor
necrosis factor (TNF) expression in macrophages and IL-6
expression in fibroblasts.
IL-2 is mostly secreted by T4 cells but, it can also be
secreted by T-8 cells medullary thymocytes and giant
granule lymphocytes. It leads to endothelial permeability
increase and leak syndrome due to the secretion of various
cytokines.
IL-6 is released by T and B lymphocytes, monocytes,
endothelial cells, epithelial cells and fibroblasts. It is an
indicator of an acute inflammatory response. IL-6 level in
plasma rises proportionally to the tissue damage caused by
the surgeon and the inflammatory response induced by
CPB.
IL-10 inhibits TH1 (T helper lymphocytes) and natural
cells’ cytokine production. It increases B cell proliferation
and antibody production and inhibits cellular immunity. By
inhibiting TNF-a and nitrous oxide (NO) production, endo-
gen IL-10 has a role in the protection of myocardium during
ischemic reperfusion.
TNF is composed of two peptides called TNF-a and TNF-
b. TNF-a is an endogenous pyrogen and an acute phase
reactant secreted by activated macrophages. TNF-a has
role in local neutrophilic infiltration, tumor necrosis,
cachexia, and neutrophilia, and it has radioprotective ef-
fects at the same time. TNF-a, like proinflammatory cyto-
kines, may individually turn into potential harmful
mediators, when their plasma levels increase
substantially.10
Oxygenators are accused of causing hemolysis because
of abrupt pressure changes and increased surface tension.
Perfusion through an oxygenator increases platelet mem-
brane fragility, leading to increased possibility of hemoly-
sis, which then decreases after a 24-hour period. Further
trauma to blood components can be caused by the aspira-
tion system.2 One of the accused tools leading to coagula-
tion cascade activation and inflammatory responses is the
“oxygenator” and numerous attempts have been made to
change its surface with the hope of preventing these
catastrophic events. Therefore, we investigated the effects
of coating style (albumin or synthetic peptide) used in ox-
ygenators within various hematologic and clinical
parameters.
2. Materials and methods
Twenty-seven patients undergoing elective coronary artery
bypass grafting (CABG) were included in the study. Our
exclusion criteria among the patients was as follows: any
anticoagulant, steroid or anti-inflammatory drug usage
within the last 7 days prior to enrollment, previous bypass
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cedures. The patients were randomly allocated into two
groups based on oxygenators used. In Group I, albumin-
coated (Jostra REF VKMO 4230, Hirrlingen, Germany)
oxygenator was used (n Z 14, male:female ratio Z 10:4,
mean age Z 58  8 years), and in Group II, a synthetic
peptide-coated oxygenator (Jostra REF VKMO 4200, Hirr-
lingen, Germany) was used (n Z 13, male:female Z 10:3,
mean age Z 58  10 years).
A radial artery and a central vein were cannulated in all
patients. Pentothal sodium 3e4 mg/kg, cisatracurium
(Nimbex) 0.15e0.2 mg/kg and fentanyl were used for
anesthesia induction. Thereafter, fentanyl (100 mg) and
Nimbex (0.02 mg/kg with 30-minute intervals) were used
for anesthesia. Intravenous heparin (5 mg/kg) was given for
systemic heparinization, which was neutralized with prot-
amine sulfate following the cessation of extracorporeal
circulation. We preferred isothermic blood cardioplegia and
abstained from steroid drugs during the surgery. In the case
of a low preoperative hemoglobin level, erythrocyte sus-
pension was added to the individual patient’s prime volume
(Isolyte S 1000 mL, Gelofusine 500 mL, mannitol 100 mL,
heparin 50 mg, 3 ampule NaHCO3, antibiotic). Blood sam-
ples were taken from radial artery at the following time
points:
T1: Following anesthesia induction, just before surgical
incision.
T2: 5 minutes after the removal of cross-clamp.
T3: At 6th hour from the start of CPB surgery.
T4: At 24th hour from the start of CPB surgery.
The blood taken in flat test tubes was allowed to stand
at þ4C until it became decomposed with a 10-minute
centrifugation in 3000 rotation. The decomposed sera were
kept at 70C in a deep freeze. C1inhib, C3c, and C4 were
studied using the nephelometric method with a Behring
Nephelometer Analyzer device, and the results were indi-
cated in terms of g/dL.
IL-1b, IL2, IL-6, and IL-10 were studied by the ELISA
method using immunoassay kits (BioSource International,
Inc USA). The results were obtained by using a Biotek ELISA
reader at 450 nm and interleukin results were calculated as
picograms (pg)/mL.Table 1 Statistical comparison of demographic and operationa
Group I
Age (y) 58  8
Sex 4 females,
BSA (m2) 1.84  0.14
Duration of pump (min) 69.28  35.
Duration of cross clamping (min) 39.4  21.8
Temperature (C) 29.28  2.1
HTC in CPB (%) 21.5  3.34
0e4 h drainage (mL) 338.8  244
4e8 h drainage (mL) 155.7  75.
8e12 h drainage (mL) 91.15  104
Post-operative blood transfusion (unit) 1  1.22
BSA Z body surface area; CPB Z cardiopulmonary bypass; HTC Z heTNF-a was studied by the ELISA method using immuno-
assay kits (BioSource International, Inc USA). The results
were obtained by using Biotek ELISA reader at 450 nm.
Hemoglobin, hematocrit, leukocyte, and platelet counts
were analyzed with a Coulter Max M mode device. More-
over, we also used an Olympus AU 5200 machine for
determining total protein and albumin levels.
Drainage and transfused blood volumes were recorded at
4-hour intervals at 0, 8, and 12 hours postoperatively.
2.1. Statistical analysis
Variables were expressed as a mean for standard deviation.
To compare groups, Student t test and Mann-Whitney U test
were used according to the normality test results assessed
by Kolmogorov-Smirnov test. A p value less than 0.05 was
considered as significant.
3. Results
There were no statistically significant differences between
the groups in terms of age, gender, body surface area,
cross-clamp time, body temperature during bypass, he-
matocrit, and drainage volumes corrected by time and
transfusion requirements (Table 1).
Total protein, hematocrit, and platelet count values
were similar in both of the groups at the same intervals.
Albumin levels were significantly lower in Group I at time 2
(Table 2). Group I patients had also significantly higher
white blood cell count 24 hours after surgery.
Postoperative total protein, albumin, hematocrit, and
platelet counts were significantly lower, and white blood
cell counts were significantly higher in both of the groups.
C1, C3, and C4 checked at four different intervals had no
statistical difference in both groups (p > 0.05). While C1,
C3, and C4 prominently decreased in surgery, a slight in-
crease was observed following CPB (Fig. 1).
Statistical comparisons and levels of cytokines between
Group I and Group II are shown in Table 3. Regarding Group
II, the increase of TNF-a in T1eT3 was significant
(p < 0.05), while the decrease in T3eT4 was not significant
(p > 0.05). In Group I, the increase of TNF-a in T1eT3 was
very significant (p < 0.01), while the increase in T1eT4 wasl variables in Group I and Group II.
Group II p
58  10 NS
10 males 3 females, 10 males NS
1.91  0.15 NS
37 78.38  23.8 NS
43.3  13.6 NS
9 29.23  1.3 NS
23.76  3.72 NS
266.9  167 NS
7 132.6  104.2 NS
.16 105.7  109.5 NS
0.61  1.19 NS
matocrit; NS Z not significant.
Table 2 Statistical comparison of laboratory variables in
Group I and Group II.
Group I Group II p
Albumin (mg/dL)
T1 3.60  0.28 3.76  0.29 NS
T2 2.65  0.23 2.97  0.41 <0.05
Total protein (mg/dL)
T1 7.4  0.50 6.93  0.60 NS
T2 4.73  0.42 4.81  1.09 NS
HTC (%)
T1 40.7  4.46 40.69  5.21 NS
T2 29.2  4.86 32.53  3.62 NS
Platelet count/mL
T1 272,642  69,540 231,461  79,234 NS
T2 122,714  41,244 146,000  50,146 NS
WBC/mL
T1 8240  3035 8018  3244 NS
T2 12,164  2837 11,528  2684 <0.05
HTC Z hematocrit; NS Z not significant; T1 Z following
anesthesia induction but just before surgical incision; T2 Z at
24th hour from starting point of cardiopulmonary bypass sur-
gery; WBC Z white blood cell.
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difference of TNF-a levels in T4 time between the two
groups.
Neither IL-1 nor IL-2 was found in the plasma of both the
groups. This shows that there was no pattern difference
among them.
In Group I, there had been a significant increase in IL-6
level (7.857  25.01 pg/mL) from the start of the operation
(p < 0.001). In IL-6, we could see a decrease in T3 and T4
(608.28  82.62 and 486.78  153.86 pg/mL) (p < 0.05), but
over the T1 value, there was a level of T4. There was a
significant increase in IL-10 (p < 0.001). We could see an
insignificant decrease in T10 between T3 and T4Figure 1 The levels of complement in Groups I and II (g/dL).
C Z complement; CPB Z cardiopulmonary bypass;
dL Z deciliter; g Z gram; T1 Z just after the anesthesia in-
duction before surgical incision; T2 Z 5 minutes after the
removal of cross-clamp; T3 Z 6 hours after the start of CPB;
T4 Z 24 hours after the start of CPB.(16.14  33.64 and 14.028  37.36 pg/mL) (p > 0.05), but
the T4 level was over T1.
When we look at the cytokines in Group II, we see a
significant increase in IL-6 level as the operation is started
up (p < 0.05). IL-6 showed an increase in T3eT4 but it was
not significant (p < 0.05). The increase of IL-10 in T3eT4
(26.97  30.03 to 4.061  5.27 pg/mL) was significant
(p < 0.01).
There was a significant difference between IL-6 in T2,
T3, and T4 levels (Fig. 3) and IL-10 in the T3 level
(p < 0.001) (Fig. 4). IL-10 was significantly high in Group II
(T3) (p < 0.05). In Group I, IL-6 in T2, T3, and T4 levels
were found to be significantly high (p < 0.001).4. Discussion
Previous studies have suggested that the oxygenator
coating type may affect protein absorption and platelet
adhesion-aggregation. Moreover, the postoperative clinical
course may also be better depending on the oxygenator
coating type. The use of biocompatible membranes in the
extracorporeal circulation can decrease the side-effects
related to blood element-membrane interactions.1 The
protein coating provides a hydrophilic surface via electro-
statics and van der Waal’s forces. This electrically inactive
surface creates a milieu that prevents fibrinogen binding,
leading to platelet activation.
Polypeptide impregnation is a safe and an effective op-
tion for oxygenator coating.12 Albumin coating may prevent
platelet activation and consumption during CPB only for
some time.13
Blood-synthetic membrane interaction in the extracor-
poreal circulation leads to thrombocytopenia, discharge of
platelet granule contents and thromboxane synthesis.
Subsequently, subcellular degeneration and a decrease in
thrombocyte sensitivity may ensue. The changes in throm-
bocyte count and functions lengthen the bleeding time and
result in significant blood loss. Factor XII is also activated by
blood-nonbiological membrane interaction. This activation
triggers intrinsic coagulation pathway. Mechanical trauma
caused by the oxygenator itself may jeopardize both pro-
teins and platelets in the extracorporeal circulation sys-
tem. Thrombocyte function and count are further adversely
affected by this kind of trauma.14,15 Denaturized proteins
increase red blood cell grouping and red cell vulnerability
to shear stress.1,2,14,16e18 Thrombocyte and neutrophil ac-
tivations have an important role in reperfusion injury.
White blood cells are very important to define acute
inflammation during the first 6-24 hours.19 In our study, we
found a decrease in postoperative platelet and hematocrit
levels in both groups. The difference between the groups
was not significant (p > 0.05).
Postoperative drainage can be affected by several non-
surgical factors, such as: platelet dysfunction and inflam-
matory response. The previous studies for albumin coating
showed contradictions on postoperative drainage and
transfusion requirements.20 We did not find any significant
difference about drainage volume and postoperative
transfusion needs in our study.
It was detected that the levels of C3 and C4 decreased
during CPB and the levels of C3a and C4a increased because
Table 3 Statistical comparison and levels of cytokines in
Group I and Group II.
Cytokines
(pg/mL)
Group I Group II p
IL-1 (T1) 0 0.0615  0.22 NS
IL-1 (T2) 0 0 NS
IL-1 (T3) 0 0.146  0.36 NS
IL-1 (T4) 0 0.53  1.91 NS
IL-2 (T1) 0 0.348  0.643 NS
IL-2 (T2) 0 0.361  0.83 NS
IL-2 (T3) 0 0.216  0.475 NS
IL-2 (T4) 0.107  0.305 0.103  0.202 NS
IL-6 (T1) 7.857  25.01 1.461  3.619 NS
IL-6 (T2) 92.642  106.9 17.61  24.07 <0.05
IL-6 (T3) 608.28  82.62 255.38  69.55 <0.05
IL-6 (T4) 486.78  153.86 285.69  88.2 <0.05
IL-10 (T1) 0.528  1.58 0.476  1.71 NS
IL-10 (T2) 35.52  41.01 51.64  62.58 NS
IL-10 (T3) 16.14  33.64 26.97  30.03 <0.05
IL-10 (T4) 14.028  37.36 4.061  5.27 NS
TNF-a (T1) 0.776  1.67 3.39  5.64 NS
TNF-a (T2) 4.014  11.56 3.47  5.36 NS
TNF-a (T3) 44.71  115.76 13.81  17.43 NS
TNF-a (T4) 3.69  5.79 5.97  9.11 NS
CPB Z cardiopulmonary bypass; mL Z milliliter; NS Z not
significant; pg Z picogram; T1 Z just after the anesthesia in-
duction before surgical incision; T2 Z 5 minutes after the
removal of cross clamp; T3 Z 6 hours after the start of CPB;
T4 Z 24 hours after the start of CPB.
Figure 3 The levels of IL-6 in Groups I and II (pg/mL).
CPB Z cardiopulmonary bypass; IL Z interleukin;
mLZ milliliter; pgZ picogram; T1Z just after the anesthesia
induction before surgical incision; T2 Z 5 minutes after the
removal of cross-clamp; T3 Z 6 hours after the start of CPB;
T4 Z 24 hours after the start of CPB.
Coated oxygenators and inflammatory response syndrome 97of activation.12 C3a increased with the start of CPB and
reached itsmaximum level at theendof thebypass. C3a level
depends on the length of the bypass and reverts back to its
standard level after 48 hours. The complements increase
with the contact activation, but is devastated by the pump.
Therefore, the detection of the initial increase and decrease
in the complement levels come into prominence. It is iden-
tified that, in the studies carried out using oxygenatorsFigure 2 TNF-a exchange ratio. CPB Z cardiopulmonary
bypass; T1 Z just after the anesthesia induction before sur-
gical incision; T2 Z 5 minutes after the removal of cross-
clamp; T3 Z 6 hours after the start of CPB; T4 Z 24 hours
after the start of CPB; TNF-a Z tumor necrosis factor alpha.coated with protein, the level of C5b-9 (membrane attack
complex) is less high compared to the others.21
TNF-a is a potent proinflammatory cytokine. This may
turn into harmful mediators when plasma levels are high in
pathologic cases such as major trauma, sepsis, and shock.10
It is mostly associated with ischemicereperfusion dam-
age.17,22e25 It can lead to hemorrhagic necrosis by its syn-
ergistic effect with complement. The increase in TNF-a
starts with the beginning of CPB and reaches its maximum
value 1 hour after the end of CPB.26 There is some research
in the literature that observe that there is no systemic TNF-
a secretion in normothermic CPB.27 In some cases, levels of
TNF-a remain normal during CPB.27,28 The significant in-
crease in TNF-a is seen at the end of this technique, but in
other research, it is shown to occur after the aortic cross-
clamp removal. The endogen mediators such as TNF-a, IL-
1, and IL-6 are important adhesion molecules during the
acute inflammatory phase.29
In Group I of our study, we saw a significant increase in
TNF-a after cross-clamp removal, but that showed no
relation to the start of CPB. We also got the same result in
Group II of the study.
When we looked at TNF-a levels that increased after the
cross-clamp removal in both groups, we got results that are
in agreement with those in literature. Even though the in-
crease in Group I TNF-a level in T1 and T3 is quite signifi-
cant, there was no statistical difference between the
groups (p > 0.05).
It has been shown that cytokine secretion after cardiac
surgery is increased and proinflammatory cytokine response
level is proportional to ischemic time.30 Pro-inflammatory
cytokines can cause damage to myocardial contractility.
Recently, it was observed that there was a relation be-
tween the increase in cytokine levels, left ventricular wall
damage, and myocardial ischemia.
There was no observed secretion of IL-1b during
normothermic CPB and there has been no measurement of
IL-1 level in any patient.27 Even after hypothermic bypass,
IL-1 was not found in plasma. In both groups of our study,
we could not detect any IL-1 and IL-2 levels in plasma. This
has made us think that there is not any free IL-1 and IL-2 in
plasma. However, it has been considered that during CPB,
Figure 4 The levels of IL-10 in Groups I and II (pg/mL).
CPB Z cardiopulmonary bypass; IL Z interleukin;
mLZmilliliter; pgZ picogram; T1Z just after the anesthesia
induction before surgical incision; T2 Z 5 minutes after the
removal of cross-clamp; T3 Z 6 hours after the start of CPB;
T4 Z 24 hours after the start of CPB.
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and affects the inflammatory response.
In both the groups, we saw a significant increase in IL-6
and IL-10 levels after the start of CPB. Six hours after the
start of CPB, there was a significant increase in IL-6 level,
while IL-10 levels were observed to be insignificantly
decreased. However, in Group II, there was a significant
increase in IL-10 levels (p < 0.05), but IL-6 levels were
significantly low (p < 0.01). Here we observed the anti-
inflammatory IL-10 effect which decreased the IL-6 level.
According to these results, the synthetic peptide-coated
oxygenator used during CPB seems to have specifically
induced the systemic inflammatory response. As a result,
we might say that in Group II patients, the IL system seems
to be activated toward the induction of the anti-
inflammatory response.
The synthetic peptide-coated oxygenator showed an
inflammatory effect by increasing the IL-levels in the acute
phase. The IL-6 level in Group II seemed to be less
increased when compared to Group I. In albumin-coated
group, the increase in IL-6 and IL-10 levels in the first phase
seems to be statistically significant. Although IL-10 levels
were higher at T2 and T3 time points, it was only signifi-
cantly higher at T3 in Group II. Albumin-coated oxygenators
induce, mostly, the inflammatory response, while synthetic
peptide-coated oxygenators after the initial phase of CPB
induce a significant anti-inflammatory response.
We detected lower postoperative total protein and al-
bumin levels in both groups probably due to protein
breakdown and adhesion to the nonbiological membrane
during extracorporeal circulation. This decrease reached
statistical significance for albumin levels only in the
albumin-coated group. This may suggest a less inactive
membrane surface in the polypeptide-coated group.
The therapy aiming to equilibrate the inflammatory re-
actions after the cardiac surgery may decrease the
myocardial damage and incidence level of complications. In
Group I, IL-6 was found to be high. The substantial increase
in the IL-6 level has a more harmful effect on the organism
by its pro-inflammatory action when compared to its anti-
inflammatory character. In Group II, the significant highlevel of IL-10 shows that anti-inflammatory character is
more effective. Furthermore, the low level of albumin and
high level of white blood cells in Group I shows that blood
has been exposed to trauma. According to these results,
the usage of synthetic polypeptide-coated oxygenator
seems to be quite reasonable. We believe that with the
improvement of technology, other types of coated oxy-
genators will be invented, which might lead to a decrease
in SIRS in minimal levels.References
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